Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
R-Biopharm is a global leader in clinical diagnostics and food/feed analysis with a broad portfolio of commercialized products for laboratory and point-of-care testing. The company has launched several notable diagnostic solutions including RT-PCR assays for SARS-CoV‑2 detection and rapid antigen tests during the COVID‑19 pandemic. It is recognized for high precision, safety, and quality standards with multiple ISO certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on R-Biopharm.